ConvaTec Group PLC (CNVVY)

13.60 -0.62 (-4.39%) At close: 10:48AM EDT

ConvaTec Group PLC

20 Eastbourne Terrace
7th Floor
London W2 6LG
United Kingdom

https://www.convatecgroup.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 10,136

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Karim Bitar	CEO & Director	3.7M	N/A	1965
Mr. Jonathan Peter Mason	Group CFO & Director	1.98M	N/A	1964
Mr. John Haller	Executive VP and Chief Quality & Operations Officer	N/A	N/A	N/A
Dr. Divakar Ramakrishnan Ph.D.	Executive VP, Chief Technology Officer and Head of Research & Development	N/A	N/A	N/A
Ms. Kate Postans	Vice President of Investor Relations & Corporate Communications	N/A	N/A	N/A
Ms. Evelyn Douglas J.D.	Executive VP, Chief of Corporate Strategy & Business Development and General Counsel	N/A	N/A	N/A
Ms. Moyra Withycombe	Interim Chief People Officer	N/A	N/A	N/A
Ms. Kjersti Grimsrud Biotechnology, M.Sc.	President & COO of Infusion Care	N/A	N/A	1961
Mr. David Shepherd	President & COO of Global Advanced Wound Care	N/A	N/A	N/A
Mr. Seth R. Segel	President and COO of Continence Care & Home Services Group	N/A	N/A	1969

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Corporate Governance

ConvaTec Group PLC’s ISS Governance QualityScore as of April 1, 2024 is 2. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 1; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.